1 citations · 1 across the 2 of their papers we have counts for
2 papers
q-bio.GN2017
Discovery of new drug therapeutic indications from gene mutation information for hepatocellular carcinoma
Liang Yu, Fengdan Xu, Lin Gao
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. However, cure is not possible with currently us…
q-bio.TO2017★ 1 cited
Predicting therapeutic and aggravating drugs for hepatocellular carcinoma based on tissue-specific pathways
Liang Yu, Fengdan Xu, Lin Gao
Motivation: Hepatocellular carcinoma (HCC) is a significant health problem worldwide and annual number of cases are nearly more than 700,000. However,there are few safe and effecti…